265 related articles for article (PubMed ID: 31129353)
1. Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.
Kurosawa S; Yamaguchi T; Oshima K; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1851-1858. PubMed ID: 31129353
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5.
Kurosawa S; Yamaguchi T; Mori A; Tsukagoshi M; Okuda I; Ikeda M; Fuji S; Yamashita T; Ogawa C; Ito A; Tanaka T; Inamoto Y; Kim SW; Fukuda T
Transplant Cell Ther; 2021 Nov; 27(11):935.e1-935.e9. PubMed ID: 34371214
[TBL] [Abstract][Full Text] [Related]
4. Coping and Modifiable Psychosocial Factors are Associated with Mood and Quality of Life in Patients with Chronic Graft-versus-Host Disease.
Jacobs JM; Fishman S; Sommer R; Sereno I; Fenech A; Jankowski AL; Traeger L; Greer JA; Vanderklish J; Hunnewell C; Saylor M; Chen YB; Spitzer T; DeFilipp Z; Temel JS; El-Jawahri A
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2234-2242. PubMed ID: 31260800
[TBL] [Abstract][Full Text] [Related]
5. Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation.
Gruber I; Koelbl O; Herr W; Holler E; Edinger M; Wolff D
Radiat Oncol; 2022 Nov; 17(1):195. PubMed ID: 36447269
[TBL] [Abstract][Full Text] [Related]
6. A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease.
Patel SS; Hong S; Rybicki L; Farlow S; Dabney J; Kalaycio M; Sobecks R; Majhail NS; Hamilton BK
Transplant Cell Ther; 2023 Jul; 29(7):465.e1-465.e7. PubMed ID: 37003415
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and recovery after graft-versus-host disease.
Baker KS; Fraser CJ
Best Pract Res Clin Haematol; 2008 Jun; 21(2):333-41. PubMed ID: 18503996
[TBL] [Abstract][Full Text] [Related]
8. Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.
Sun YC; Chai X; Inamoto Y; Pidala J; Martin PJ; Flowers ME; Shen TT; Lee SJ; Jagasia M
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1687-91. PubMed ID: 26033283
[TBL] [Abstract][Full Text] [Related]
9. Quality of life associated with acute and chronic graft-versus-host disease.
Lee SJ; Kim HT; Ho VT; Cutler C; Alyea EP; Soiffer RJ; Antin JH
Bone Marrow Transplant; 2006 Aug; 38(4):305-10. PubMed ID: 16819438
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia.
Kurosawa S; Yamaguchi T; Mori T; Kanamori H; Onishi Y; Emi N; Fujisawa S; Kohno A; Nakaseko C; Saito B; Kondo T; Hino M; Nawa Y; Kato S; Hashimoto A; Fukuda T
Bone Marrow Transplant; 2015 Sep; 50(9):1241-9. PubMed ID: 26076127
[TBL] [Abstract][Full Text] [Related]
11. Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.
El-Jawahri A; Pidala J; Inamoto Y; Chai X; Khera N; Wood WA; Cutler C; Arora M; Carpenter PA; Palmer J; Flowers M; Weisdorf D; Pavletic S; Jaglowski S; Jagasia M; Lee SJ; Chen YB
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1341-8. PubMed ID: 24813171
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
[TBL] [Abstract][Full Text] [Related]
13. Health-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101.
El Jurdi N; Martens MJ; Brunstein CG; O'Donnell P; Lee SJ; D'Souza A; Logan B; Hong S; Singh AK; Sandhu K; Shapiro RM; Horowitz MM; Hamilton BK
Transplant Cell Ther; 2023 Jul; 29(7):467.e1-467.e5. PubMed ID: 37088401
[TBL] [Abstract][Full Text] [Related]
14. Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success.
Kawamura K; Nakasone H; Kurosawa S; Yoshimura K; Misaki Y; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Kusuda M; Kameda K; Wada H; Ishihara Y; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Kanamori H; Mori T; Takahashi S; Taniguchi S; Atsuta Y; Kanda Y
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1521-1526. PubMed ID: 29476953
[TBL] [Abstract][Full Text] [Related]
15. Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study.
Riemens A; Te Boome LC; Kalinina Ayuso V; Kuiper JJ; Imhof SM; Lokhorst HM; Aniki R
Acta Ophthalmol; 2014 Feb; 92(1):82-7. PubMed ID: 23601505
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.
Pidala J; Kurland B; Chai X; Majhail N; Weisdorf DJ; Pavletic S; Cutler C; Jacobsohn D; Palmer J; Arai S; Jagasia M; Lee SJ
Blood; 2011 Apr; 117(17):4651-7. PubMed ID: 21355084
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and Risk Factors of Relapse after Allogeneic Stem Cell Transplantation in Children with Leukemia: A Long-Term Follow-Up Single-Center Study.
Molina B; Gonzalez Vicent M; Herrero B; Deltoro N; Ruiz J; Perez Martinez A; Diaz MA
Biol Blood Marrow Transplant; 2019 Jan; 25(1):100-106. PubMed ID: 30142415
[TBL] [Abstract][Full Text] [Related]
18. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
[TBL] [Abstract][Full Text] [Related]
19. Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma.
Jeon YW; Yoon S; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG
Ann Hematol; 2019 Jul; 98(7):1743-1753. PubMed ID: 31089793
[TBL] [Abstract][Full Text] [Related]
20. "Is this the GVHD?" A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service.
de Vere Hunt I; Kilgour JM; Danby R; Peniket A; Matin RN
Health Qual Life Outcomes; 2021 Jan; 19(1):11. PubMed ID: 33413414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]